I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Lauri, Birgitta
70
results:
Search for persons
X
Format
Online (70)
Mediatypes
E-Books (1)
Articles (Online) (19)
OpenAccess-fulltext (50)
Languages
german (1)
english (66)
Sorted by: Relevance
Sorted by: Year
?
1
Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment w..:
Partanen, Anu
;
Waage, Anders
;
Peceliunas, Valdas
...
Cancers. 16 (2024) 5 - p. 1024 , 2024
Link:
https://doi.org/10.3390/..
?
2
P898: A PROSPECTIVE PHASE 2 STUDY TO ASSESS MINIMAL RESIDUA..:
Silvennoinen, Raija
;
Partanen, Anu
;
Waage, Anders
...
HemaSphere. 7 (2023) S3 - p. e5534069 , 2023
Link:
https://doi.org/10.1097/..
?
3
Idelalisib (PI3Kδ inhibitor) therapy for patients with rela..:
Mattsson, Agnes
;
Sylvan, Sandra Eketorp
;
Axelsson, Per
...
European Journal of Haematology. 111 (2023) 5 - p. 715-721 , 2023
Link:
https://doi.org/10.1111/..
?
4
Longitudinal minimal residual disease assessment in multipl..:
Schmitz, Alexander
;
Brøndum, Rasmus Froberg
;
Johnsen, Hans Erik
...
BMC Cancer. 22 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1186/..
?
5
P-222: A prospective phase 2 study to assess minimal residu..:
Silvennoinen, Raija
;
Waage, Anders
;
Peceliunas, Valdas
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S157 , 2022
Link:
https://doi.org/10.1016/..
?
6
Regional differences in treatment and outcome for myeloma p..:
Wålinder, Göran
;
Genell, Anna
;
Juliusson, Gunnar
...
Cancer Reports. 5 (2022) 11 - p. , 2022
Link:
https://doi.org/10.1002/..
?
7
P-184: Regional differences in treatment and outcome for my..:
Wålinder, Göran
;
Genell, Anna
;
Juliusson, Gunnar
...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S138 , 2021
Link:
https://doi.org/10.1016/..
?
8
Daratumumab, bortezomib, and dexamethasone in relapsed or r..:
Weisel, Katja
;
Spencer, Andrew
;
Lentzsch, Suzanne
...
Journal of Hematology & Oncology. 13 (2020) 1 - p. , 2020
Link:
https://doi.org/10.1186/..
?
9
Over 10 years relative median survival in MM patients ≤ 65 ..:
Blimark, Cecilie Hveding
;
Genell, Anna
;
Lund, Johan
...
Clinical Lymphoma Myeloma and Leukemia. 19 (2019) 10 - p. e209 , 2019
Link:
https://doi.org/10.1016/..
?
10
Lenalidomide versus lenalidomide + dexamethasone prolonged ..:
Lund, Johan
;
Gruber, Astrid
;
Lauri, Birgitta
...
Cancer Medicine. 7 (2018) 6 - p. 2256-2268 , 2018
Link:
https://doi.org/10.1002/..
?
11
Pharmacogenetic study of the impact of ABCB1 single-nucleot..:
Jakobsen Falk, Ingrid
;
Lund, Johan
;
Gréen, Henrik
...
Cancer Chemotherapy and Pharmacology. 81 (2017) 1 - p. 183-193 , 2017
Link:
https://doi.org/10.1007/..
?
12
Depth of Response and MRD with Daratumumab Plus Bortezomib ..:
Spencer, Andrew
;
Mark, Tomer
;
Spicka, Ivan
...
Clinical Lymphoma Myeloma and Leukemia. 17 (2017) 1 - p. e85 , 2017
Link:
https://doi.org/10.1016/..
?
13
European Post-Approval Safety Study (EU Pass) of Relapsed/R..:
Di Raimondo, Francesco
;
Kyriakou, Charalampia
;
Schmidt-Hieber, Martin
...
Clinical Lymphoma Myeloma and Leukemia. 17 (2017) 1 - p. e62 , 2017
Link:
https://doi.org/10.1016/..
?
14
Improved survival in myeloma patients: starting to close in..:
Liwing, Johan
;
Uttervall, Katarina
;
Lund, Johan
...
British Journal of Haematology. 164 (2013) 5 - p. 684-693 , 2013
Link:
https://doi.org/10.1111/..
?
15
Idelalisib (PI3K delta inhibitor) therapy for patients with..:
Mattsson, Agnes
;
Sylvan, Sandra Eketorp
;
Axelsson, Per
...
European Journal of Haematology, 0902-4441, 2023, 111:5, s. 715-721. , 2023
Link:
http://urn.kb.se/resolve..
1-15